CRISPR/Cas9 Screen in Gastric Cancer Patient-Derived Organoids Reveals KDM1A-NDRG1 Axis as a Targetable Vulnerability.
Mircetic J, Camgöz A, Abohawya M, Ding L, Dietzel J, Tobar SG, Paszkowski-Rogacz M, Seidlitz T, Schmäche T, Mehnert MC, Sidorova O, Weitz J, Buchholz F, Stange DE.
Mircetic J, et al. Among authors: buchholz f.
Small Methods. 2023 Jun;7(6):e2201605. doi: 10.1002/smtd.202201605. Epub 2023 Mar 12.
Small Methods. 2023.
PMID: 36908010
However, their application in new, more physiologically relevant culturing systems like patient-derived organoids (PDOs) has been much slower. ...De-repression of NDRG1 by KDM1A inhibitors (KDM1Ai) causes inhibition of Wnt signaling and a strong G1 cell cycle arrest …
However, their application in new, more physiologically relevant culturing systems like patient-derived organoids (PDOs) has been muc …